Stem Cells, Patents and Regulation in China: Inadequacy
2016
Despite the bright future of HESC research in conquering incurable diseases, its development faces many legal and ethical challenges. The complexity of HESC research creates most unusual and fraught situations for regulators in China.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI